COVID-19 Treatment Candidates, at a Glance
October
14
More than a year into the pandemic, a handful of vaccines have been authorized for the novel coronavirus in the U.S., yet there is still no cure for COVID-19. Researchers and doctors have been racing to find drugs and therapies that could treat the disease or prevent people from getting infected. Only one drug, Gilead Sciences’ Veklury (remdesivir), has been approved by the FDA, while several treatments received an emergency use authorization (EUA). Here’s a look at some of the key treatments/candidates currently in play:
© 2024 MMIT
Meet Our Reporters
-
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile